The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
Open accessAbstract
Carbapenem-resistant Acinetobacter baumannii (CRAB) is a perilous nosocomial pathogen causing substantial morbidity and mortality. Current treatment options for CRAB are limited and suffer from pharmacokinetic limitations, such as high toxicity and low plasma levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142
Self-citationAcinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Self-citationSchooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., & Spellberg, B. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-16 · Cited by 1,170
Self-citationPhage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
Paul, M., Daikos, G. L., Durante-Mangoni, E., Yahav, D., Carmeli, Y., Benattar, Y. D., Skiada, A., Andini, R., Eliakim-Raz, N., Nutman, A., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30099-9 · Cited by 623
Landman, D., Georgescu, C., Martin, D. A., & Quale, J. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-08 · Cited by 565
Cai, Y., Chai, D., Wang, R., Liang, B., & Bai, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks084 · Cited by 557
Durante-Mangoni, E., Signoriello, G., Andini, R., Mattei, A., De Cristoforo, M., Murino, P., Bassetti, M., Malacarne, P., Petrosillo, N., Galdieri, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit253 · Cited by 405
Ito, A., Sato, T., Ota, M., Takemura, M., Nishikawa, T., Toba, S., Kohira, N., Miyagawa, S., Ishibashi, N., Matsumoto, S., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01454-17 · Cited by 400
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Qureshi, Z. A., Hittle, L. E., O'Hara, J. A., Rivera, J. I., Syed, A., Shields, R. K., Pasculle, A. W., Ernst, R. K., & Doi, Y. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ048 · Cited by 395
Self-citationCisek, A. A., Dąbrowska, I., Gregorczyk, K. P., & Wyżewski, Z. (2017) · Current Microbiology · doi:10.1007/s00284-016-1166-x · Cited by 318
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
Zhanel, G. G., Cheung, D., Adam, H., Zelenitsky, S., Golden, A., Schweizer, F., Gorityala, B., Lagacé-Wiens, P. R. S., Walkty, A., Gin, A. S., et al. (2016) · Drugs · doi:10.1007/s40265-016-0545-8 · Cited by 317
Durand-Réville, T. F., Guler, S., Comita-Prevoir, J., Chen, B., Bifulco, N., Huynh, H., Lahiri, S., Shapiro, A. B., McLeod, S. M., Carter, N. M., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.104 · Cited by 285
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
Freire, A. T., Melnyk, V., Kim, M. J., Datsenko, O., Dzyublik, O., Glumcher, F., Chuang, Y.-C., Maroko, R. T., Dukart, G., Cooper, C. A., et al. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.05.012 · Cited by 284
Solomkin, J., Evans, D., Slepavicius, A., Lee, P., Marsh, A., Tsai, L., Sutcliffe, J. A., & Horn, P. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2016.4237 · Cited by 276
Lood, R., Winer, B. Y., Pelzek, A. J., Diez-Martinez, R., Thandar, M., Euler, C. W., Schuch, R., & Fischetti, V. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04641-14 · Cited by 272
Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection
LaVergne, S., Hamilton, T., Biswas, B., Kumaraswamy, M., Schooley, R. T., & Wooten, D. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy064 · Cited by 239
Sirijatuphat, R., & Thamlikitkul, V. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02435-13 · Cited by 235
Sutcliffe, J. A., O'Brien, W., Fyfe, C., & Grossman, T. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-13 · Cited by 235
Hackel, M. A., Tsuji, M., Yamano, Y., Echols, R., Karlowsky, J. A., & Sahm, D. F. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01968-17 · Cited by 235
AYDEMIR, H., AKDUMAN, D., PISKIN, N., COMERT, F., HORUZ, E., TERZI, A., KOKTURK, F., ORNEK, T., & CELEBI, G. (2013) · Epidemiology and Infection · doi:10.1017/s095026881200194x · Cited by 225
Viehman, J. A., Nguyen, M. H., & Doi, Y. (2014) · Drugs · doi:10.1007/s40265-014-0267-8 · Cited by 215
Self-citationCombination therapy for carbapenem-resistant Gram-negative bacteria
Paul, M., Carmeli, Y., Durante-Mangoni, E., Mouton, J. W., Tacconelli, E., Theuretzbacher, U., Mussini, C., & Leibovici, L. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku168 · Cited by 210
Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii
McConnell, M. J., Rumbo, C., Bou, G., & Pachón, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.001 · Cited by 204
Hackel, M. A., Tsuji, M., Yamano, Y., Echols, R., Karlowsky, J. A., & Sahm, D. F. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00093-17 · Cited by 202
Ito, A., Kohira, N., Bouchillon, S. K., West, J., Rittenhouse, S., Sader, H. S., Rhomberg, P. R., Jones, R. N., Yoshizawa, H., Nakamura, R., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv402 · Cited by 192
Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
Ito-Horiyama, T., Ishii, Y., Ito, A., Sato, T., Nakamura, R., Fukuhara, N., Tsuji, M., Yamano, Y., Yamaguchi, K., & Tateda, K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03098-15 · Cited by 187
Regeimbal, J. M., Jacobs, A. C., Corey, B. W., Henry, M. S., Thompson, M. G., Pavlicek, R. L., Quinones, J., Hannah, R. M., Ghebremedhin, M., Crane, N. J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02877-15 · Cited by 187
Zusman, O., Altunin, S., Koppel, F., Dishon Benattar, Y., Gedik, H., & Paul, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw377 · Cited by 169
Kucers' The Use of Antibiotics
(2017) · CRC Press eBooks · doi:10.1201/9781498747967 · Cited by 169
Papp‐Wallace, K. M., Nguyen, N. Q., Jacobs, M. R., Bethel, C. R., Barnes, M. D., Kumar, V., Bajaksouzian, S., Rudin, S. D., Rather, P. N., Bhavsar, S., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00091 · Cited by 168
Self-citationHua, Y., Luo, T., Yang, Y., Dong, D., Wang, R., Wang, Y., Xu, M., Guo, X., Hu, F., & He, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02659 · Cited by 166
Wright, M. S., Haft, D. H., Harkins, D. M., Perez, F., Hujer, K. M., Bajaksouzian, S., Benard, M. F., Jacobs, M. R., Bonomo, R. A., & Adams, M. D. (2014) · mBio · doi:10.1128/mbio.00963-13 · Cited by 165
Self-citationvan Duin, D., Perez, F., Rudin, S. D., Cober, E., Hanrahan, J., Ziegler, J., Webber, R., Fox, J., Mason, P., Richter, S. S., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02636-14 · Cited by 165
Self-citationOn-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy
Mattila, S., Ruotsalainen, P., & Jalasvuori, M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01271 · Cited by 165
Kengkla, K., Kongpakwattana, K., Saokaew, S., Apisarnthanarak, A., & Chaiyakunapruk, N. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx368 · Cited by 164
Doi, Y., Bonomo, R. A., Hooper, D. C., Kaye, K. S., Johnson, J. R., Clancy, C. J., Thaden, J. T., Stryjewski, M. E., & van Duin, D. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw829 · Cited by 154
Self-citationLivermore, D. M., Mushtaq, S., Warner, M., & Woodford, N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00436-16 · Cited by 152
Dobias, J., Tendon, V. D., Poirel, L., & Nordmann, P. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3063-z · Cited by 151
Corbett, D. F., Wise, A., Langley, T., Skinner, K., Trimby, E., Birchall, S., Dorali, A., Sandiford, S. K., Williams, J., Warn, P. A., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00200-17 · Cited by 148
Abdallah, M., Olafisoye, O., Cortes, C. D., Urban, C. M., Landman, D., & Quale, J. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04809-14 · Cited by 144
Leitner, L., Sybesma, W., Чанішвілі, Н., Goderdzishvili, M., Chkhotua, A. B., Ujmajuridze, A., Schneider, M. P., Sartori, A. M., Mehnert, U., Bachmann, L. M., et al. (2017) · BMC Urology · doi:10.1186/s12894-017-0283-6 · Cited by 144
Isolation and characterization of ϕAB2: a novel bacteriophage of Acinetobacter baumannii
Lin, N., Chiou, P.-Y., Chang, K., Chen, L., & Lai, M. (2010) · Research in Microbiology · doi:10.1016/j.resmic.2010.03.007 · Cited by 140
Ghosh, M., Miller, P. A., Möllmann, U., Claypool, W. D., Schroeder, V. A., Wolter, W. R., Suckow, M. A., Yu, H., Li, S., Huang, W., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00102 · Cited by 136
McConnell, M. J., & Pachón, J. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.052 · Cited by 132
Betrosian, A. P., Frantzeskaki, F. G., Xanthaki, A., & Georgiadis, G. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540600951184 · Cited by 131
Falagas, M. E., Skalidis, T., Vardakas, K. Z., Legakis, N. J., & on behalf of the Hellenic Cefiderocol Study Group (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx049 · Cited by 122
Seifert, H., Stefanik, D., Sutcliffe, J. A., & Higgins, P. G. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.06.022 · Cited by 108
Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A Review
Lashinsky, J. N., Henig, O., Pogue, J. M., & Kaye, K. S. (2017) · Infectious Diseases and Therapy · doi:10.1007/s40121-017-0153-2 · Cited by 102
Matsumoto, S., Singley, C. M., Hoover, J. L., Nakamura, R., ECHOLS, R. M., Rittenhouse, S. F., Tsuji, M., & Yamano, Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00700-17 · Cited by 101
Monogue, M. L., Tsuji, M., Yamano, Y., ECHOLS, R. M., & Nicolau, D. P. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01022-17 · Cited by 101
Esterly, J. S., Griffith, M. M., Qi, C., Malczynski, M., Postelnick, M. J., & Scheetz, M. H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01728-10 · Cited by 96
Kusradze, I., Karumidze, N., Rigvava, S., Dvalidze, T., Katsitadze, M., Amiranashvili, I., & Goderdzishvili, M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01590 · Cited by 94
Nielsen, T. B., Pantapalangkoor, P., Luna, B. M., Bruhn, K. W., Yan, J., Dekitani, K., Hsieh, S., Yeshoua, B. J., Pascual, B., VINOGRADOV, E. V., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix315 · Cited by 94
Self-citationLiang, C.-A., Lin, Y.-C., Lu, P., Chen, H.-C., Chang, H.-M., & Sheu, C. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.10.033 · Cited by 92
Phage Abp1 Rescues Human Cells and Mice from Infection by Pan-Drug Resistant Acinetobacter Baumannii
Yin, S., Huang, G., Zhang, Y., Jiang, B., Yang, Z., Dong, Z.-W., You, B. R., Yuan, Z., Hu, F., Zhao, Y., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000486117 · Cited by 86
Shen, G., Wang, J., Wen, F.-S., Chang, K., Kuo, C.-F., Lin, C.-H., Luo, H.-R., & Hung, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046537 · Cited by 82
LpxC inhibitors: a patent review (2010-2016)
Kalinin, D. V., & Holl, R. (2017) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1360282 · Cited by 82
Lin, S. X. W., & Balthasar, J. P. (2018) · Antibodies · doi:10.3390/antib7010005 · Cited by 74
Kang, A. D., Smith, K. P., Eliopoulos, G. M., Berg, A. H., McCoy, C. P., & Kirby, J. E. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.03.006 · Cited by 73
McLeod, S. M., Shapiro, A. B., Moussa, S. H., Johnstone, M. R., McLaughlin, R. E., DeJonge, B. L. M., & Miller, A. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01576-17 · Cited by 69
Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection
Chen, Z., Chen, Y., Fang, Y.-G., Wang, X., Chen, Y., Qi, Q., Huang, F., & Xiao, X. (2015) · Scientific Reports · doi:10.1038/srep17091 · Cited by 60
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii
García‐Quintanilla, M., Caro‐Vega, J. M., Pulido, M. R., Moreno-Martínez, P., Pachón, J., & McConnell, M. J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00407-16 · Cited by 44
Phagebiotics in treatment and prophylaxis of healthcare-associated infections
Aleshkin, A. V., Ershova, O. N., Валентинович, В. Н., Ea, S., Popova, A. V., Rubalskii, E., Borzilov, A. I., Aleshkin, V. A., Ss, A., Karaulov, A. V., et al. (2016) · Bacteriophage · doi:10.1080/21597081.2016.1251379 · Cited by 44
Vázquez-Ucha, J. C., Maneiro, M., Martínez-Guitián, M., Buynak, J. D., Bethel, C. R., Bonomo, R. A., Bou, G., Poza, M., González‐Bello, C., & Beceiro, A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01172-17 · Cited by 43
Self-citationLN-1-255, a penicillanic acid sulfone able to inhibit the class D carbapenemase OXA-48
Vallejo, J. A., Martínez-Guitián, M., Vázquez-Ucha, J. C., González‐Bello, C., Poza, M., Buynak, J. D., Bethel, C. R., Bonomo, R. A., Bou, G., & Beceiro, A. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw105 · Cited by 40
Self-citationTitécat, M., Liang, X., Lee, C., Charlet, A., Hocquet, D., Lambert, T., Pagès, J., Courcol, R., Sebbane, F., Toone, E. J., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw210 · Cited by 31
Lemaître, N., Liang, X., Najeeb, J., Lee, C., Titécat, M., Leteurtre, E., Simonet, M., Toone, E. J., Zhou, P., & Sebbane, F. (2017) · mBio · doi:10.1128/mbio.00674-17 · Cited by 30
Portsmouth, S., van Veenhuyzen, D., ECHOLS, R. M., et al. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx163.1399 · Cited by 26
Correction: Investigation of Indazole Unbinding Pathways in CYP2E1 by Molecular Dynamics Simulations
Shen, Z., Cheng, F., Xu, Y., Fu, J., Xiao, W., Shen, J., Liu, G., Li, W., & Tang, Y. S. (2012) · PLoS ONE · doi:10.1371/annotation/86d9f6df-7175-467c-a9ff-94eac53af128 · Cited by 25
Lee, Y., Wang, Y.-C., Kuo, S., Chen, C.-T., Liu, C.-P., Liu, Y.-M., Chen, T.-L., & Yang, Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00931-17 · Cited by 17
Tsuji, M., Hackel, M., ECHOLS, R. M., et al. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx163.895 · Cited by 7
Cited by
Diekema, D. J., Hsueh, P.-R., Mendes, R. E., Pfaller, M. A., Rolston, K. V., Sader, H. S., & Jones, R. N. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00355-19 · Cited by 645
Metals to combat antimicrobial resistance
Frei, A., Verderosa, A. D., Elliott, A. G., Zuegg, J., & Blaskovich, M. A. T. (2023) · Nature Reviews Chemistry · doi:10.1038/s41570-023-00463-4 · Cited by 638
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
Jean, S.-S., Harnod, D., & Hsueh, P.-R. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.823684 · Cited by 366
Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review
Parmanik, A., Das, S., Kar, B., Bose, A., Dwivedi, G. R., & Pandey, M. M. (2022) · Current Microbiology · doi:10.1007/s00284-022-03061-7 · Cited by 277
Metadata
- Authors
- Isler, B., Doi, Y., Bonomo, R. A., & Paterson, D. L.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2019-01
- Volume
- 63
- Issue
- 1
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2896374296
- Cited by
- 293
- References
- 73
- FWCI
- 9.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.